These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8837356)

  • 21. Monoclonal anti-K14 and anti-K2.
    Nichols ME; Rosenfield RE; Rubinstein P
    Vox Sang; 1987; 52(3):231-5. PubMed ID: 3300028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kell expression on myeloid progenitor cells.
    Wagner T; Lanzer G; Geissler K
    Leuk Lymphoma; 2002 Mar; 43(3):479-85. PubMed ID: 12002749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three uncommon KEL alleles in one family with unusual Kell phenotypes explain a 35-year old conundrum.
    Karamatic Crew V; Poole J; Burton N; Daniels G
    Vox Sang; 2014 Apr; 106(3):242-7. PubMed ID: 24795954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein.
    Jaber A; Loirat MJ; Willem C; Bloy C; Cartron JP; Blanchard D
    Br J Haematol; 1991 Oct; 79(2):311-5. PubMed ID: 1958490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A murine monoclonal antibody against Kx protein which reacts also with beta-spectrin.
    Carbonnet F; Blanchard D; Hattab C; Cochet S; Petit-Leroux Y; Loirat MJ; Cartron JP; Bertrand O
    Transfus Med; 2000 Jun; 10(2):145-54. PubMed ID: 10849386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on 5 monoclonal antibody samples directed against antigens in the Kell blood group system.
    Zelinski T; Kaita H; Coghlan G; Lewis M
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):391-4. PubMed ID: 3212319
    [No Abstract]   [Full Text] [Related]  

  • 30. Acquired loss of red cell Kell antigens.
    Vengelen-Tyler V; Gonzalez B; Garratty G; Kruppe C; Johnson CL; Mueller KA; Marsh WL
    Br J Haematol; 1987 Feb; 65(2):231-4. PubMed ID: 3828231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terminology for red cell surface antigens. ISBT Working Party Oslo Report. International Society of Blood Transfusion.
    Daniels GL; Anstee DJ; Cartron JP; Dahr W; Garratty G; Henry S; Jørgensen J; Judd WJ; Kornstad L; Levene C; Lomas-Francis C; Lubenko A; Moulds JJ; Moulds JM; Moulds M; Overbeeke M; Reid ME; Rouger P; Scott M; Seidl S; Sistonen P; Tani Y; Wendel S; Zelinski T
    Vox Sang; 1999; 77(1):52-7. PubMed ID: 10474091
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of human and chimpanzee Kell blood group systems.
    Redman CM; Lee S; ten Huinink D; Rabin BI; Johnson CL; Oyen R; Marsh WL
    Transfusion; 1989; 29(6):486-90. PubMed ID: 2749871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry and quantification of antigen sites.
    Parsons SF; Gardner B; Anstee DJ
    Transfus Med; 1993 Jun; 3(2):137-42. PubMed ID: 7690639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a defect in the intracellular trafficking of a Kell blood group variant.
    Yazdanbakhsh K; Lee S; Yu Q; Reid ME
    Blood; 1999 Jul; 94(1):310-8. PubMed ID: 10381527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen.
    Redman CM; Marsh WL; Scarborough A; Johnson CL; Rabin BI; Overbeeke M
    Br J Haematol; 1988 Jan; 68(1):131-6. PubMed ID: 3345289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hemolytic anemia and the Kell blood groups.
    Marsh WL; Oyen R; Alicea E; Linter M; Horton S
    Am J Hematol; 1979; 7(2):155-62. PubMed ID: 539592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and persistence of anti-Kell after transfusion of Kell-positive blood.
    Schabel A; König AL; Schiebel MR; Sugg U
    Beitr Infusionsther Transfusionsmed; 1994; 32():175-8. PubMed ID: 9422111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.